ArticleMaterials today. Bio2025
Whitlockite-loaded silk fibroin/polyvinyl alcohol hydrogel composited with porous tantalum scaffold enhances bone regeneration and immunomodulation via the TGF-β/NRROS signaling pathway.
Article in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bone defects, caused by diseases or trauma, significantly impact patients' quality of life. While porous Tantalum (pTa) scaffolds have shown promise in bone defect repair due to their excellent properties, their bioinert nature cannot meet the bioactive stimulation required for bone regeneration. To address these challenges, this study designed a composite scaffold composed of a 3D-printed pTa scaffold and a silk fibroin-crosslinked polyvinyl alcohol (SP) hydrogel loaded with whitlockite (WH). WH, a secondary inorganic component of bone tissue, was incorporated into the hydrogel to enhance its osteogenic, angiogenic and anti-inflammatory properties. The optimal proportions of PVA and WH were determined through extensive experiments. The resulting scaffold, designated as SP-pTa@WH, demonstrated remarkable biocompatibility and effectively promoted bone tissue repair in vitro and in vivo. Mechanistic studies revealed that SP-pTa@WH significantly modulated macrophage polarization towards the M2 phenotype and upregulated the expression of key osteogenic genes. High-throughput gene sequencing analysis further identified the TGF-β signaling pathway, particularly the NRROS gene, as critical in mediating the anti-inflammatory effects of SP-pTa@WH. Overall, this study provides a novel composite scaffold with enhanced osteogenic and immunomodulatory capabilities, offering broad prospects for clinical applications in bone defect repair.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.